IKS Earns Best in KLAS Recognition for 4th Consecutive Year

Best in KLAS 2022 Software and Services

February 9, 2022 – Cary, NC – AQuity Solutions has been recognized by KLAS Research as the 2022 Best in KLAS Transcription Service.  This marks the fourth consecutive year AQuity has earned the recognition based on random surveys of active clients of competing industry vendors.  KLAS rankings are considered the gold standard in the Health Information Management and Revenue Cycle Management industries for their accurate, honest, and impartial research analytics.


“Our continued success with KLAS shows why it’s so important to invest in quality, security, and customer satisfaction,” noted Regina Buchwald, VP of AQuity’s Transcription Services division.  “As the industry continues to evolve, there are still certain specialties and complex workflow scenarios where transcription is still the most cost-effective way to document.  We see this recognition as validation of our unwavering commitment to the discipline and our ongoing transcription service business strategy.”


“Our comprehensive Transcription solutions have led the industry for many years,” added Jason Kolinoski, AQuity’s COO.  “As we’ve extended our offerings with industry leading Virtual Scribe and Coding solutions, we are committed to helping our clients reduce costs, improve the quality of documentation, and increase value across the middle revenue cycle.  Earning top rankings in all three disciplines, based on multiple industry client surveys, while continuing to grow the business during COVID, speaks volumes about our entire team and our commitment to client outcomes.”

“We take KLAS rankings very seriously and put a high priority on our performance across all business units,” added Kashyap Joshi, AQuity’s CEO.  “Winning our 4th consecutive recognition for transcription services based on client surveys is very gratifying.  We are very proud of how our team continues to lead the industry.”

About IKS Health

IKS Health takes on the chores of healthcare—spanning administrative, clinical, and operational burdens—so that clinicians can focus on their core tasks of medical care delivery. Combining pragmatic technology and dedicated experts, IKS enables stronger, financially sustainable enterprises. IKS’s Care Enablement Platform delivers data-driven value and expertise across the care journey, and IKS is a partner for clinician enterprises looking to effectively scale, improve quality and achieve cost savings through forward-thinking solutions. Founded in 2006, IKS’s technology-enabled solutions and global workforce supports large health systems, medical groups and risk bearing entities across the United States. For more information, visit ikshealth.com.

Inventurus Knowledge Solutions Limited is proposing, subject to receipt of requisite approvals, market conditions and other considerations, to make an initial public offer of its equity shares, and has filed a draft red herring prospectus (“DRHP”) with the Securities and Exchange Board of India (“SEBI”). The DRHP is available on the website of SEBI at www.sebi.gov.in as well as on the websites of the book running lead managers, ICICI Securities Limited, JM Financial Limited, J.P. Morgan India Private Limited, Jefferies India Private Limited and Nomura Financial Advisory and Securities (India) Private Limited, at https://www.icicisecurities.com, https://www.jmfl.com/, www.jpmipl.com, www.jefferies.com and www.nomuraholdings.com/company/group/asia/india/index.html respectively, and the websites of the stock exchange(s) at www.nseindia.com and www.bseindia.com, respectively. Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risk, see “Risk Factors” of the RHP, when available. Potential investors should not rely on the DRHP for any investment decision.

Media Contact – IKS Health
Sarah Bennight
Senior Vice President
sarah.bennight@ikshealth.com

Contact – IKS Health India:
Srushti Rao
VP Communications, IKS Health
+91 98203 94009
srushti.rao@ikshealth.com

Share this post